NCT04912024

Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study

Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study (COMPARE)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 458 (actual)
• Sponsor: Outset Medical · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

Retrospective, multicenter, comparative, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Renal Disease or Acute Kidney Injury.

Conditions

• End Stage Kidney Disease
• End Stage Renal Disease
• Acute Kidney Injury

Interventions

Type	Name	Description
DEVICE	Intermittent Renal Replacement Therapy using the Tablo Hemodialysis System	Intermittent renal replacement therapy using the Tablo Hemodialysis System in the acute setting for participants with AKI or ESKD
DEVICE	Intermittent Renal Replacement Therapy using Conventional Hemodialysis Systems	Intermittent renal replacement therapy using Conventional Hemodialysis Systems in the acute setting for participants with AKI or ESKD

Timeline

• Start date: 2021-05-15
• Primary completion: 2022-06-15
• Completion: 2022-06-15
• First posted: 2021-06-03
• Last updated: 2022-08-12

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated device study